JO
ALXO icon

John Overdeck’s ALX Oncology ALXO Stock Holding History

John Overdeck’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51M Buy
2,178,176
+590,343
+37% +$1.06M ﹤0.01% 2235
2026
Q1 		$3.18M Buy
1,587,833
+947,628
+148% +$1.81M ﹤0.01% 2395
2025
Q4 		$723K Buy
640,205
+33,534
+6% +$50.8K ﹤0.01% 3117
2025
Q3 		$1.11M Buy
606,671
+128,737
+27% +$111K ﹤0.01% 2508
2025
Q2 		$198K Sell
477,934
-64,721
-12% -$32.7K ﹤0.01% 2917
2025
Q1 		$338K Sell
542,655
-161,476
-23% -$194K ﹤0.01% 2668
2024
Q4 		$1.18M Buy
704,131
+44,072
+7% +$67.7K ﹤0.01% 2076
2024
Q3 		$1.2M Buy
660,059
+367,833
+126% +$1.37M ﹤0.01% 2018
2024
Q2 		$1.76M Buy
292,226
+226,771
+346% +$2.79M ﹤0.01% 1633
2024
Q1 		$730K Sell
65,455
-466
-0.7% -$6.54K ﹤0.01% 2141
2023
Q4 		$982K Buy
+65,921
New +$625K ﹤0.01% 2092
2023
Q2 		– Sell
-108,351
Closed -$490K – 2988
2023
Q1 		$490K Buy
108,351
+62,351
+136% +$472K ﹤0.01% 2217
2022
Q4 		$518K Sell
46,000
-60,652
-57% -$681K ﹤0.01% 2001
2022
Q3 		$1.02M Sell
106,652
-137,820
-56% -$1.61M ﹤0.01% 1465
2022
Q2 		$1.98M Buy
244,472
+97,377
+66% +$1.06M 0.01% 1212
2022
Q1 		$2.49M Sell
147,095
-242,107
-62% -$4.13M 0.01% 1246
2021
Q4 		$8.36M Buy
389,202
+386,302
+13,321% +$16.7M 0.02% 885
2021
Q3 		$214K Buy
+2,900
New +$193K ﹤0.01% 3918

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

John Overdeck's ALXO Position: Q2 2026 in Review

John Overdeck increased its ALX Oncology (ALXO) stake by 37% in Q2 2026, buying an estimated $1.06M and bringing the position to 2,178,176 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

John Overdeck first reported a position in ALXO in Q3 2021 and has held it in 18 quarters since. The position peaked at $8.36M in Q4 2021. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • John Overdeck held 2,178,176 shares of ALX Oncology worth $4.51M as of Q2 2026.
  • John Overdeck bought 590,343 ALX Oncology shares in Q2 2026, an estimated $1.06M.
  • ALX Oncology made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2235 holding.
  • John Overdeck first reported a position in ALX Oncology in Q3 2021 and has held it in 18 quarters since.
  • John Overdeck's ALX Oncology position peaked at $8.36M in Q4 2021.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.